During Q4, the company billed 11,789 tissue-based units and 12,036 liquid-based units, representing growth of 50% and 10%, respectively.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener